Doussis I A, Gatter K C, Mason D Y
Nuffield Department of Pathology, John Radcliffe Hospital, Oxford.
J Clin Pathol. 1993 Apr;46(4):334-6. doi: 10.1136/jcp.46.4.334.
To investigate the presence of the macrophage associated antigen CD68 in non-haematopoietic tumours.
Cytological specimens from non-macrophage derived tumours were stained using the alkaline phosphatase anti-alkaline phosphatase immunocytochemical method (APAAP) and three monoclonal anti-CD68 antibodies, Y1/82A, EBM11, and KP1.
Reactivity of malignant cells with one or more of the antibodies was seen in 11 out of 40 adenocarcinomas and in one of seven poorly differentiated carcinomas; other neoplasms, including 10 cases of squamous carcinoma, three of malignant melanoma, and four of oat cell carcinoma were negative. Monoclonal antibody KP1 gave the strongest staining and reacted with the highest proportion of neoplastic cells.
CD68 is expressed in a proportion of epithelial tumours although the labelling is usually less intense than in macrophages. Anti-CD68 antibodies should therefore be used as part of a panel in the diagnosis of poorly differentiated neoplasms in cytological material.
研究巨噬细胞相关抗原CD68在非造血系统肿瘤中的存在情况。
采用碱性磷酸酶抗碱性磷酸酶免疫细胞化学方法(APAAP)以及三种抗CD68单克隆抗体Y1/82A、EBM11和KP1,对非巨噬细胞来源肿瘤的细胞学标本进行染色。
40例腺癌中有11例、7例低分化癌中有1例的恶性细胞与一种或多种抗体发生反应;其他肿瘤,包括10例鳞状细胞癌、3例恶性黑色素瘤和4例燕麦细胞癌均为阴性。单克隆抗体KP1染色最强,与最高比例的肿瘤细胞发生反应。
CD68在一部分上皮性肿瘤中表达,尽管其标记强度通常低于巨噬细胞。因此,抗CD68抗体应作为细胞学材料中低分化肿瘤诊断检测组合的一部分使用。